Bioresorbable Activa IM-Nail™ shows convincing results in Post-Market Clinical Follow-up study for the treatment of children's forearm fractures |
| June 01, 2022 | June 2022 Bond Updates |
|
HELSINKI, June 1, 2022 /PRNewswire/ -- Bioretec Ltd (HELSINKI: BRETEC) Forearm fractures are a common injury in children and adolescents. When operative treatment is needed, intramedullary nailing with elastic titanium nail (ESIN) is the most common surgical procedure. On many occasions,... |
| View more at: https://www.prnewswire.com:443/news-releases/bioresorbable-activa-im-nail-shows-convincing-results-in-post-market-clinical-follow-up-study-for-the-treatment-of-childrens-forearm-fractures-301558771.html |
| Related News |
|